[{"id":"266c441e-217f-4fdb-b291-e341689e4674","acronym":"","url":"https://clinicaltrials.gov/study/NCT04628988","created_at":"2021-01-19T20:36:06.920Z","updated_at":"2024-07-02T16:35:37.303Z","phase":"Phase 1","brief_title":"A Study of CC-90011 and Comparators in Participants With Prostate Cancer","source_id_and_acronym":"NCT04628988","lead_sponsor":"Celgene","biomarkers":" AR","pipe":" | ","alterations":" AR expression","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AR expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xtandi (enzalutamide) • abiraterone acetate • prednisone • pulrodemstat (CC-90011)"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 07/28/2021","start_date":" 07/28/2021","primary_txt":" Primary completion: 05/26/2023","primary_completion_date":" 05/26/2023","study_txt":" Completion: 05/26/2023","study_completion_date":" 05/26/2023","last_update_posted":"2023-09-13"}]